Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics
Open accessPublished version of a preprint
The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Abstract
Initial replication of SARS-CoV-2 in the upper respiratory tract is required to establish infection, and the replication level correlates with the likelihood of viral transmission. Here, we examined the role of host innate immune defenses in restricting early SARS-CoV-2 infection using transcriptomics and biomarker-based tracking in serial patient nasopharyngeal samples and experiments with airway epithelial organoids. SARS-CoV-2 initially replicated exponentially, with a doubling time of ∼6 h, and induced interferon-stimulated genes (ISGs) in the upper respiratory tract, which rose with viral replication and peaked just as viral load began to decline. Rhinovirus infection before SARS-CoV-2 exposure accelerated ISG responses and prevented SARS-CoV-2 replication. Conversely, blocking ISG induction during SARS-CoV-2 infection enhanced viral replication from a low infectious dose. These results show that the activity of ISG-mediated defenses at the time of SARS-CoV-2 exposure impacts infection progression and that the heterologous antiviral response induced by a different virus can protect against SARS-CoV-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure S1. iRegulon analysis of transcription factor–binding sites enriched in RNA from control subjects compared with SARS-CoV-2–positive patients. Related to Fig 1. (A) Transcription factor (TF) motifs/track–binding sites enriched in NP RNA from control subjects. Bars show strength of association (normalized enrichment score [NES]) with motifs/tracks and associated transcription factors. Transcription factors associated with regulation of neuronal tissue–specific genes are highlighted in red. (B and C) Targets of transcription factors REST (B) and POU3F2 (C) enriched in NP RNA from control subjects. Red text indicates targets previously shown to be more highly expressed in olfactory compared with respiratory epithelium. Asterisks indicate transcripts also enriched in olfactory sensory neurons (olfactory epithelium, respiratory epithelium, and olfactory sensory neuron expression data are from Olender et al., 2016).](https://figures.cochat.ai/paper-figures/5437738b2df74031b1ef04c237863203/dynamic-innate-immune-response-determines-susceptibility-to-sars-cov-2-infection-figure-3.jpg)

![Figure S2. Relationship between age or sex and and NP CXCL10 in 140 SARS-CoV-2–positive patients. Related to Fig 2. (A) Age distribution of 140 patients studied. (B) Sex distribution of 140 patients studied. (B) Sex distribution and inpatient/outpatient status of 140 patients studied. (C) Comparison of age in outpatients versus admitted patients. Number of patients shown in parentheses. Groups were compared by unpaired t test, with P value shown. (D) Correlation analysis showing lack of significant correlation between age and NP CXCL10 protein level, based on 140 patients. (E and F) Comparison of NP CXCL10 protein level (E) and viral load (F) based on age and inpatient/outpatient status. No significant differences were detected between groups by unpaired t test. (G and H) Correlation between viral load and NP CXCL10 in all patients (G) and outpatients (H) in all patients or patients segregated by sex. For all patients, according to simple linear regression analysis, the slope of all samples is significantly nonzero (r2 = 0.2030, P < 0.0001), but slopes are not significantly different for each sex. For outpatients only, the slope of the regression line is not significantly nonzero, likely due to lower numbers (male [M] outpatient, n = 18; female [F] outpatient, n = 20).](https://figures.cochat.ai/paper-figures/f83a4b2a8b464401b03922b5e6153e7e/dynamic-innate-immune-response-determines-susceptibility-to-sars-cov-2-infection-figure-5.jpg)








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Previous studies of viral infection using this model considered gene expression in each cell type, but not heterogeneous response patterns, which may be of biological and clinical relevance in understanding the tissue response to respiratory virus infections44,45.”
From Causal identification of single-cell experimental perturbation effects with CINEMA-OT (2023) · cites this paper as [44]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As expected, in response to RV infection, most epithelial cell types exhibited robust induction of the interferon response, with upregulation of several interferon-stimulated genes, including ISG15, IFI44, STAT1, MX1, and others (Fig. 4c,d)44.”
From Causal identification of single-cell experimental perturbation effects with CINEMA-OT (2023) · cites this paper as [44]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype
Kim, D., Paggi, J. M., Park, C., Bennett, C., & Salzberg, S. L. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0201-4 · Cited by 15,022
StringTie enables improved reconstruction of a transcriptome from RNA-seq reads
Pertea, M., Pertea, G. M., Antonescu, C. M., Chang, T.-C., Mendell, J. T., & Salzberg, S. L. (2015) · Nature Biotechnology · doi:10.1038/nbt.3122 · Cited by 14,298
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Zou, L., Ruan, F., Huang, M., Liang, L., Huang, H., Hong, Z., Yu, J., Kang, M., Song, Y., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,810
Temporal dynamics in viral shedding and transmissibility of COVID-19
He, X., Lau, E. H. Y., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y. C., Wong, J. Y., Guan, Y., Tan, X., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0869-5 · Cited by 4,247
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Research works printed but not linked: 2
- Banerjee, A.K., M.R. Blanco, E.A. Bruce, D.D. Honson, L.M. Chen, A. Chow, P. Bhat, N. Ollikainen, S.A. Quinodoz, C. Loney,. 2020 b. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses. Cell. 183: 1325– 1339.e21. 10.1016/j.cell.2020.10.004 33080218 PMC7543886 · DOI · Paper page
- Centers for Disease Control and Prevention. 2021 a. Emerging SARS-CoV-2 Variants. https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/scientific-brief-emerging-variants.html (accessed January 8, 2021). 34009774
Cited by
Items 201–211 of 211
COVID-19 severity biomarkers identified by transcriptomics: a scoping review
Oliveira, T. T., de Medeiros, V. P. B., Freitas, J. F., Silva, G. M. M., Xavier, T. J. D. S., & Agnez‐Lima, L. F. (2026) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2026.2651977
dos Santos, E. H., Barreira, G. A., Saippa, M. O., Franco, L. A. M., Rocha, M. C., Kanunfre, K. A., Pereira, M. F. B., Marques, H. H. D. S., & Okay, T. S. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11885-w
Gowanlock, S. N., Lam, V. H. K., Tepe, Z. G., Park, D. E., Tai, V., Salazar, J. E., Pham, T., Khan, Y. N., Nelson, S., Horn, C., et al. (2026) · Respiratory Research · doi:10.1186/s12931-026-03697-0
Microbial imprinting of the airway epithelium
van de Ven, J. J. I., Amatngalim, G. D., Garssen, J., Netea, M. G., & Perdijk, O. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117705
Cell-autonomous immunity as an integrated immune network against bacterial and viral pathogens
Martín-González, L., Ramos, B., Huang, Y., Thurston, T. L. M., Towers, G. J., & Lobato‐Márquez, D. (2026) · Nature Microbiology · doi:10.1038/s41564-026-02428-x
Idowu, T., Fecko, D. P., Eichner, H., Bee, G. C. W., Knoop, K. A., Weiser, J. N., & Lokken-Toyli, K. L. (2026) · Mucosal Immunology · doi:10.1016/j.mucimm.2026.100399
Maslov, D. E., Osipov, I. D., Zabelina, D. S., Demina, D. S., Tomilova, Y. E., Berdieva, S. B., Makukha, V. V., Komissarova, T. V., Agletdinov, E. F., & Sv, N. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1882419
SARS-CoV-2 Coinfections and Severity in Hospitalized Children With Systematic Testing
Chiara, C. D., Farrar, D. S., Bettinger, J. A., Campigotto, A. J., Drouin, O., Embreé, J., Halperin, S. A., Jadavji, T., Kazmi, K., Papenburg, J., et al. (2026) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000005396
Fraser, R., Schwarze, J., & Dockrell, D. H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1924673
Viral subversion of B-cell tolerance: mechanisms linking infection to autoimmunity
Fraczek, M., Salem, G. M., Melano, I., Tan, X. N. S., Lim, C. S. M., & Chen, W. (2026) · EMBO Reports · doi:10.1038/s44319-026-00959-2
Westrhenen, E. S. E. M. H.-V., de Hoog, M. L. A., Winkel, A. M. A. M., Junquera, L., Lavell, A. H. A., de Jong, M. D., van Houten, M. A., van Lelyveld, S. F. L., Eggink, D., Euser, S. M., et al. (2026) · Epidemiology and Infection · doi:10.1017/s0950268826102088
Metadata
- Authors
- Cheemarla, N. R., Watkins, T. A., Mihaylova, V. T., Wang, B., Zhao, D., Wang, G., Landry, M. L., & Foxman, E. F.
- Affiliations
- Yale University (US)
- Corresponding author
- Foxman, Ellen F.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2021-06-15
- Volume
- 218
- Issue
- 8
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC8210587
- OpenAlex
- W3169110632
- Cited by
- 213
- References
- 101
- Citations by year
- 2026: 20 · 2025: 31 · 2024: 36 · 2023: 39 · 2022: 65 · 2021: 22
- FWCI
- 12.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (submittedVersion, cc-by-nc-nd)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- Funders
- George Mason University
- Yale
- China Scholarship Council
- Gruber Foundation
- National Institutes of Health (T32AI007019)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, innate immunity, interferon-stimulated genes, viral replication kinetics, upper respiratory tract, rhinovirus, nasopharyngeal viral load, infection susceptibility, virus transmission
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.